secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001437749-25-024705
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta Q3 revenue flat at $144M; non-GAAP EPS $0.19 vs $0.14 YoY; reaffirms FY2025 guidance
--------------------------------------------------------------------------------

- Revenue $144M flat YoY; organic revenue down 2%. Sample Management Solutions -4%, Multiomics +4%.
- Non-GAAP diluted EPS $0.19 (vs $0.14); GAAP EPS from cont ops $0.01 (vs ($0.00)).
- Adjusted EBITDA $18M, margin 12.3% (+260 bps); operating cash flow $26M, FCF $15M.
- FY2025 guidance reaffirmed: organic growth 3-5% and ~300 bps EBITDA margin expansion.
- Discontinued ops (B Medical) $50M non-cash impairment; total diluted EPS ($1.15).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000143774925024705/0001437749-25-024705-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000143774925024705/azta20250514_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-024705

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer